Loading...
XLONIDHC
Market cap255mUSD
Dec 23, Last price  
0.44USD
1D
-2.33%
1Q
27.21%
Jan 2017
-47.87%
IPO
-69.69%
Name

Integrated Diagnostics Holdings PLC

Chart & Performance

D1W1MN
XLON:IDHC chart
P/E
25.58
P/S
3.17
EPS
0.88
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
16.49%
Revenues
4.12b
+14.35%
641,595,747671,583,450860,231,4311,014,844,0001,170,621,0001,514,257,0001,921,452,0002,226,495,0002,656,264,0005,224,712,0003,605,047,0004,122,506,000
Net income
510m
-5.69%
24,641,81162,095,022132,768,888144,873,000260,399,000374,023,000502,092,000510,931,000594,015,0001,412,609,000541,110,000510,304,000
CFO
544m
+160.46%
639,095,868209,290,684301,587,025189,862,000398,658,000403,075,000556,308,000697,414,000882,515,0002,269,845,000208,729,000543,663,000
Dividend
Jun 16, 20220.116 USD/sh
Earnings
Mar 26, 2025

Profile

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 2,000 diagnostic test services, including immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company operates in Egypt, Jordan, Sudan, and Nigeria. As of December 30, 2021, it operated a network of 452 branch labs. The company was founded in 1979 and is headquartered in Saint Helier, Jersey.
URL
https://www.idhcorp.com/
IPO date
May 06, 2015
Employees
6,718
Domiciled in
JE
Incorporated in
JE

Valuation

Title
EGP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
4,122,506
14.35%
3,605,047
-31.00%
5,224,712
96.69%
Cost of revenue
2,999,550
2,502,367
2,737,431
Unusual Expense (Income)
NOPBT
1,122,956
1,102,680
2,487,281
NOPBT Margin
27.24%
30.59%
47.61%
Operating Taxes
268,993
327,064
739,815
Tax Rate
23.95%
29.66%
29.74%
NOPAT
853,963
775,616
1,747,466
Net income
510,304
-5.69%
541,110
-61.69%
1,412,609
137.81%
Dividends
(1,411,752)
(478,748)
Dividend yield
371.12%
62.09%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
220,384
22,675
21,721
Long-term debt
2,026,869
1,156,647
837,019
Deferred revenue
Other long-term liabilities
435,273
968,710
684,321
Net debt
1,386,745
512,746
(43,181)
Cash flow
Cash from operating activities
543,663
208,729
2,269,845
CAPEX
(323,439)
(308,838)
(263,739)
Cash from investing activities
(243,942)
990,113
(1,327,844)
Cash from financing activities
(330,461)
(1,617,687)
(647,149)
FCF
555,122
350,619
1,370,927
Balance
Cash
860,508
815,916
2,350,175
Long term investments
(149,340)
(1,448,254)
Excess cash
654,383
486,324
640,685
Stockholders' equity
3,527,909
2,148,466
2,834,989
Invested Capital
4,060,877
2,892,938
2,423,057
ROIC
24.56%
29.18%
74.32%
ROCE
23.82%
29.79%
73.24%
EV
Common stock shares outstanding
600,000
600,000
600,000
Price
0.36
-44.01%
0.63
-50.66%
1.29
16.82%
Market cap
213,000
-44.01%
380,400
-50.66%
771,000
16.82%
EV
2,774,867
1,966,863
2,059,309
EBITDA
1,524,194
1,420,023
2,725,925
EV/EBITDA
1.82
1.39
0.76
Interest
141,688
122,677
98,003
Interest/NOPBT
12.62%
11.13%
3.94%